Skip to main content
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
83.85
-2.83 (-3.26%)
At close: Apr 28, 2026, 4:00 PM EDT
84.25
+0.40 (0.48%)
Pre-market: Apr 29, 2026, 6:34 AM EDT

Kymera Therapeutics Revenue

In the year 2025, Kymera Therapeutics had annual revenue of $39.21M, down -16.70%. Kymera Therapeutics had revenue of $2.87M in the quarter ending December 31, 2025, a decrease of -61.18%.

Revenue (ttm)
$39.21M
Revenue Growth
-16.70%
P/S Ratio
174.59
Revenue / Employee
$164,752
Employees
238
Market Cap
6.85B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202539.21M-7.86M-16.70%
Dec 31, 202447.07M-31.52M-40.11%
Dec 31, 202378.59M31.77M67.84%
Dec 31, 202246.83M-26.01M-35.71%
Dec 31, 202172.83M38.80M114.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Halozyme Therapeutics 1.40B
Krystal Biotech 389.13M
ImmunityBio 113.29M
Protagonist Therapeutics 46.02M
Arcellx 22.29M
Centessa Pharmaceuticals 15.00M
Revenue Rankings

KYMR News

More News